Literature DB >> 12352383

Uric acid nephrolithiasis: current concepts and controversies.

Bijan Shekarriz1, Marshall L Stoller.   

Abstract

PURPOSE: Uric acid calculi with or without a calcium component comprise a significant proportion of urinary stones. Knowledge of the pathophysiology of stone formation is important to direct medical treatment. The aim of this review is to provide an update on the epidemiology, pathophysiology and management of uric acid renal stones.
MATERIALS AND METHODS: A MEDLINE search was performed on the topic of uric acid stones. Current literature was reviewed with regard to the epidemiology, pathophysiology, associated medical conditions and management of uric acid stones.
RESULTS: The incidence of uric acid stones varies between countries and accounts for 5% to 40% of all urinary calculi. Hyperuricuria, low urinary output and acidic urine are well known contributing factors. However, the most important factor for uric acid stone formation is persistently acidic urine. Gout and myeloproliferative disorders are associated with uric acid stones. Why most patients with gout present with acidic urine yet only 20% have uric acid stone formation remains unclear. The pathophysiological basis for persistent urine acidity also remains unclear although various mechanisms have been proposed. Urinary alkalization with potassium citrate or sodium bicarbonate is a highly effective treatment, resulting in dissolution of existing stones and prevention of recurrence.
CONCLUSIONS: Acidic urine is a prerequisite for uric acid stone formation and growth. Medical management with urinary alkalization for stone dissolution and prevention of recurrence is effective and should be the cornerstone of treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352383     DOI: 10.1097/00005392-200210010-00003

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  41 in total

Review 1.  [Evidence-based pharmacological metaphylaxis of stone disease].

Authors:  M Straub; R E Hautmann
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

2.  Role of combined use of potassium citrate and tamsulosin in the management of uric acid distal ureteral calculi.

Authors:  Osama El-Gamal; Mohamed El-Bendary; Maged Ragab; Mohamed Rasheed
Journal:  Urol Res       Date:  2011-08-21

Review 3.  Kidney stones: an update on current pharmacological management and future directions.

Authors:  Hongshi Xu; Anna L Zisman; Fredric L Coe; Elaine M Worcester
Journal:  Expert Opin Pharmacother       Date:  2013-03       Impact factor: 3.889

Review 4.  Diagnosis and management of non-calcium-containing stones in the pediatric population.

Authors:  Saritha Ranabothu; Ari P Bernstein; Beth A Drzewiecki
Journal:  Int Urol Nephrol       Date:  2018-05-30       Impact factor: 2.370

Review 5.  [Recurrence prevention of kidney stone disease].

Authors:  M Straub
Journal:  Urologe A       Date:  2011-10       Impact factor: 0.639

Review 6.  [S2k guidelines on diagnostics, therapy and metaphylaxis of urolithiasis (AWMF 043/025) : Compendium].

Authors:  T Knoll; T Bach; U Humke; A Neisius; R Stein; M Schönthaler; G Wendt-Nordahl
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

7.  [Citrate salts for calcium containing kidney stones : Prevention and treatment].

Authors:  K Wilhelm
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

8.  Difference in urinary stone composition between Uyghur and Han children with urolithiasis.

Authors:  Yang Liu; Anniwaer Yasheng; Kang Chen; Chuangxin Lan; Hamulati Tusong; Lili Ou; Yeping Liang; Hans-Göran Tiselius; Guohua Zeng; Wenqi Wu
Journal:  Urolithiasis       Date:  2016-10-15       Impact factor: 3.436

9.  Uric acid nephrolithias in the era of noncontrast computed tomography.

Authors:  Blayne K Welk; Joel M H Teichman
Journal:  Can Urol Assoc J       Date:  2008-08       Impact factor: 1.862

10.  Urinary stone analysis on 12,846 patients: a report from a single center in China.

Authors:  Wenqi Wu; Bicheng Yang; Lili Ou; Yeping Liang; Shawpong Wan; Shujue Li; Guohua Zeng
Journal:  Urolithiasis       Date:  2013-12-22       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.